Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies
Novartis
Novartis
Galapagos NV
Novartis
Incyte Corporation
Merck Sharp & Dohme LLC
Gilead Sciences
AstraZeneca
Autolus Limited
Autolus Limited
Bristol-Myers Squibb
Novartis
Novartis
Schrödinger, Inc.
Vironexis Biotherapeutics Inc.
PeproMene Bio, Inc.
Excyte Biopharma Ltd
Amgen
AstraZeneca
Pfizer
Grit Biotechnology